Marc Le Bozec

Chief Executive Officer at OSE IMMUNOTHERAPEUTICS

Health Technology

Commercial Services

Finance

Profile

Mr. Marc Le Bozec is a Chief Executive Officer & Director at OSE Immunotherapeutics SA, a Treasurer & Director at France Biotech Association, a Chief Executive Officer at CYTOO SA and a Chairman at La Financière du Faouet SASU.
He is on the Board of Directors at OSE Immunotherapeutics SA, NH TherAguix SAS, France Biotech Association, Clevexel Pharma SAS, Keranova SA, Mexbrain SAS, Monatomics Technology SAS, NG Biotech SAS, Scipio Bioscience SAS and TransCure BioServices SASU.
Mr. Le Bozec was previously employed as a Fund Manager by Financière Arbevel SA, a Chief Financial Officer & IR Contact by Cellectis SA, and a Chairman & Chief Executive Officer by BioProtein Technologies SA. He also served on the board at Takara Bio Europe AB. He received his undergraduate degree from École des Hautes Études Commerciales de Paris.

Marc Le Bozec active positions

Companies	Position	Start
NH THERAGUIX SAS	Director/Board Member	21/02/2019
OSE IMMUNOTHERAPEUTICS	Chief Executive Officer	29/09/2025
Clevexel Pharma SAS Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Director/Board Member	-
La Financière du Faouet SASU	Chairman	-
Monatomics Technology SAS	Director/Board Member	-
Keranova SA Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic	Director/Board Member	-
Scipio Bioscience SAS Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Director/Board Member	-
NG Biotech SAS NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools	Director/Board Member	-
Transcure Bioservices SAS Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform	Director/Board Member	31/12/2018
░░░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░ ░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

All active positions of Marc Le Bozec

Former positions of Marc Le Bozec

Companies	Position	End
░░░░░░░░░ ░░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░	-
░░░░░░░░░░ ░░░░░░░░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-

See the detail of Marc Le Bozec's experience

Education of Marc Le Bozec

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Le Bozec's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Financière Arbevel SA Financière Arbevel SA Investment ManagersFinance ARBEVEL is an active, long-term manager which focuses on the French small and mid-cap segment. The firm follows a pragmatic and opportunistic approach to investments in growth companies which they consider undervalued by the market or companies undergoing restructuring. They also seek to identify the companies best positioned to benefit from major structural trends including technological breakthroughs, biotechnology stakes, security, aging of the population, in order to accompany them in their development. ARBEVEL performs bottom-up, fundamental and strategic analysis of companies, including business analysis, the competitive environment, financial situation, management and valuation of the company.	Finance
Cellectis SA Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies	Health Technology
BioProtein Technologies SA BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines	Health Technology
École des Hautes Études Commerciales de Paris École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
France Biotech Association France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry	Commercial Services
Takara Bio Europe AB Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells	Commercial Services
CYTOO SA CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays	Health Technology
Clevexel Pharma SAS Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Transcure Bioservices SAS Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform	Technology Services
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Keranova SA Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic	Health Technology
Scipio Bioscience SAS Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Commercial Services
NG Biotech SAS NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools	Health Technology
NH TherAguix SAS NH TherAguix SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical and natural sciences	Commercial Services
Mexbrain SAS Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction	Health Technology
Monatomics Technology SAS
La Financière du Faouet SASU